HSBC/CALL/PFIZER INC/60/0.1/14.01.26 Stock

Warrant

DE000HG810V4

Market Closed - Bid/Ask 02:23:21 2024-06-21 EDT After market 14:00:07
0.003 EUR 0.00% Intraday chart for HSBC/CALL/PFIZER INC/60/0.1/14.01.26 0.013 +333.33%
Current month-40.00%
1 month-50.00%
Date Price Change
24-06-21 0.003 0.00%
24-06-20 0.003 0.00%
24-06-19 0.003 +50.00%
24-06-18 0.002 -33.33%
24-06-17 0.003 +50.00%

Delayed Quote Börse Stuttgart

Last update June 21, 2024 at 02:23 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying PFIZER, INC.
Issuer HSBC
WKN HG810V
ISINDE000HG810V4
Date issued 2023-02-02
Strike 60 $
Maturity 2026-01-14 (572 Days)
Parity 10 : 1
Emission price 0.3
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.3
Lowest since issue 0.001
Spread 0.01
Spread %55.56%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.74 USD
Average target price
31.92 USD
Spread / Average Target
+15.05%
Consensus